Management of peritoneal metastases from colorectal cancer and small bowel adenocarcinoma in patients with inflammatory bowel disease. [PDF]
Paramythiotis D +4 more
europepmc +1 more source
Using a multicenter Japanese colorectal cancer cohort from 25 institutions, we analyzed 1464 patients across all disease stages and tumor locations to determine the prevalence and clinicopathological features of MSI‐H/dMMR colorectal cancer. MSI‐H/dMMR tumors accounted for 9.4% of cases overall, were present in 22% of right‐sided colon cancers, and ...
Yoshihiro Morimoto +27 more
wiley +1 more source
Operative Techniques, Current Controversies, and Future Directions in the Surgical Management of Liver, Lung, and Peritoneal Metastases in Colorectal Cancer. [PDF]
Cornwell C, Raichurkar P, Koh C.
europepmc +1 more source
This study aimed to determine whether immuno‐nutritional and inflammatory markers could serve as predictors of the outcomes of postoperative adjuvant chemotherapy for stage III colorectal cancer in elderly patients. Postoperative lymphocyte‐to‐monocyte ratio and postoperative C‐reactive protein‐to‐albumin ratio accurately predicted the efficacy of ...
Tomoya Tago +6 more
wiley +1 more source
Improved detection and quantification of peritoneal metastases using delayed contrast-enhanced dual-energy CT scans. [PDF]
Bagnacci G +11 more
europepmc +1 more source
Long-Term Cytoreduction Outcomes With or Without Heated Intraperitoneal Chemotherapy For Colorectal Peritoneal Metastases. [PDF]
White MG +9 more
europepmc +1 more source
Intraperitoneal CF33-hNIS combined with PD-L1 blockade eradicates gastric cancer peritoneal metastases and prevents recurrence via durable T cell memory. [PDF]
Yang A +12 more
europepmc +1 more source
Peritoneal metastases from colorectal cancer managed by stereotactic body radiation therapy: presentation of a clinical case and review of literature. [PDF]
Bennassi A +4 more
europepmc +1 more source

